Medline Industries Recalls Reprocessed Abbott Inquiry Steerable Diagnostic Catheters Due to Potential Contamination
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP has issued a Class I recall for 311 reprocessed Abbott Inquiry Steerable Diagnostic Catheters that may contain residual material, posing serious health risks.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Medline Industries, LP has initiated a voluntary Class I recall of several models of reprocessed Abbott Inquiry Steerable Diagnostic Catheters. The recall was prompted by the discovery that certain lots may contain small particles of residual material. This is an expansion of a previous recall (Z-2610/2614-2025).
Which Products Are Affected
The recall involves 311 units distributed nationwide across the United States. All affected products are associated with Lot EP250618. The specific models and UDI-DIs include:
- 81105RH / 81172RH: 10 Elec. 2-5-2mm (UDI-DI 10197344133253, 10197344133284)
- 81202RH: 20 Elec. 2-10-2mm (UDI-DI 10197344133307)
- 81483RH: 4 Elec. 5mm (UDI-DI 10197344133444)
- 81102RH / 81104RH / 81174RH / 81531RH / 81532RH: 10 Elec. 2-5-2mm (UDI-DI 10197344133239, 10197344133246, 10197344133291, 10197344133512, 10197344133529)
- 81107RH: 10 Elec. 5mm (UDI-DI 10197344133260)
- 81402RH / 81404RH / 81405RH / 81474RH: 4 Elec. 2-5-2mm (UDI-DI 10197344133352, 10197344133376, 10197344133383, 10197344133437)
- 81473RH: 4 Elec. 5mm (UDI-DI 10197344133420)
What You Should Do
Medline Industries began notifying customers of the issue via letter on December 22, 2025. Healthcare facilities and providers should immediately check their inventory for the affected lot number (EP250618) and follow the instructions provided in the firm's notification letter regarding the return or disposal of the devices. For more information, contact Medline Industries, LP at their Northfield, Illinois headquarters.
Why This Matters
This is a Class I recall, indicating that the use of these devices poses a serious health risk. The presence of residual material in the catheters can lead to inflammatory responses, systemic infections, or thrombus reactions, which may result in life-threatening conditions such as cerebral embolism, pulmonary embolism, or deep vein thrombosis.
Source
FDA Recall Event ID 98277 - Recall Number: Z-1320-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.